RobertsonWO. Chemicals, children and research $'s. Vet Hum Toxicol1998; 40: 308–9.
2.
SmythRLWeindlingAM. Research in children: ethical and scientific aspects. Lancet1999; 354 (suppl 2): SII21–4.
3.
CampbellHSurrySAMRoyleEM. A review of randomised controlled trials published in Archives of Disease in Childhood from 1982–96. Arch Dis Child1998; 79: 192–7.
4.
GilmanJTGalP.Pharmacokinetic and pharmacodynamic data collection in children and neonates. A quiet frontier. Clin Pharmacokinet1992; 23: 1–9.
5.
Guidelines for the ethical conduct of studies to evaluate drugs in pediatric populations. Committee on Drugs, American Academy of Pediatrics. Pediatrics1995; 95: 286–94.
6.
WilsonJT. An update on the therapeutic orphan. Pediatrics1999; 104: 585–90.
7.
CoteCJKauffmanRETroendleGJLambertGH. Is the “therapeutic orphan” about to be adopted?Pediatrics1996; 98: 118–23.
8.
KopelmanLM. Children as research subjects: a dilemma. J Med Philos2000; 25: 745–64.
9.
AckermanTF. The ethics of drug research in children. Paediatr Drugs2001; 3: 29–41.
10.
GlantzLH. Research with children. Am J Law Med1998; 24: 213–44.
11.
Title 45, Code of Federal Regulations, Part 46. Protection of Human Subjects, Subpart D, Additional DHHS Protections for Children Involved as Subjects in Research; 1991 (June 18). 56 FR 28032.
LevineRJ. Randomized clinical trials. In: LevineRJ, ed. Ethics and regulation of clinical research. 2nd ed.New Haven: Yale University Press, 1988, 185–212.
14.
KramerMS. A comparison of laboratory and epidemiologic approaches to pediatric research. Pediatr Res1998; 43: 711–8.
15.
VitielloBHoagwoodK.Pediatric pharmacoepidemiology: clinical applications and research priorities in children's mental health. J Child Adolesc Psychopharmacol1997; 7: 287–90.
16.
HurwitzESBarrettMJBregmanDGunnWJPinskyPSchonbergerLB, et al. Public Health Service study on Reye's syndrome and medication. Report of the main study. JAMA1987; 257: 1905–11.
17.
KaushalRBatesDWLandriganCMcKennaKJClappMDFedericoF, et al. Medication errors and adverse drug events in pediatric inpatients. JAMA2001; 285: 2114–20.
18.
LazarouJPomeranzBHCoreyPN. Incidence of adverse drug reactions in hospitalized patients. A meta-analysis of prospective studies. JAMA1998; 279: 1200–5.
19.
FeiginRD. American Pediatric Society. Presidential Address 1998: what is the future for academic pediatrics?Pediatr Res1998; 44: 958–63.
20.
RudolphAM. American Pediatric Society. Presidential Address 1994. Reflections on research: a call to arms. Pediatr Res1994; 36: 687–91.
National Institutes of Health Web site. search.info.nih.gov (accessed 2002 Mar 11).
23.
National Institutes of Health Web site. Department of Health and Human Services, National Institutes of Health Office of the Director 2003 Budget. search.nih.gov (accessed 2002 Mar 11).
24.
HartCChessonR.Children as consumers. BMJ1998; 316: 1600–3.
25.
SimpsonLFraserI.Children and managed care: what research can, can't, and should tell us about impact. Med Care Res Rev1999; 56 (suppl 2): 13–36.
26.
Regulations Requiring Manufacturers to Assess the Safety and Effectiveness of New Drugs and Biological Products in Pediatric Patients; Final Rule; 1998 (Dec 2). 63 FR 66632.
